Literature DB >> 9597086

Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.

M Wasik1, M Blaim, D Kolewska, E Janota-Krawczyk, M Tomaszewska-Pańczyk, M Sieniawska.   

Abstract

Children on continuous ambulatory peritoneal dialysis (CAPD) in endstage renal failure are highly exposed to peritonitis. Peritoneal macrophages (PM) and blood neutrophils (PMNC) are the first line of defense against invading microbes. This study was undertaken for assessing surface receptors expression on PM and PMNC and to check their ability to phagocytosis and killing of bacteria. We have found that in spite of the decreased number of PM in dialysate fluid their viability and activity significantly increased during CAPD. Moreover, higher number of PM expressed CD16 and CD35 antigens (FcRIII and C3bR, respectively) in comparison with the results observed at CAPD onset. The number of PMNC expressed of these two antigens in uremic children blood were significantly lower in comparison with healthy control. The number of CD16 positive cells increased under influence of CAPD only temporarily. CAPD caused improvement of phagocytosis and intracellular killing of bacteria by PM but not by PMNC. There is discussed here influence of uremia and CAPD on surface antigens, function of phagocytes as well as renewal of PM during CAPD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9597086

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  2 in total

1.  IgG and complement receptor expression in children treated by peritoneal dialysis.

Authors:  Antonia H M Bouts; Jean-Claude Davin; Raymond T Krediet; Cornelis H Schröder; Leo A H Monnens; Jeroen Nauta; Jan G J van de Winkel; Theo A Out
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

2.  Elastase, α1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis.

Authors:  Bożena Polańska; Daria Augustyniak; Irena Makulska; Maria Niemczuk; Adam Jankowski; Danuta Zwolińska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-29       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.